*Department of Pathology, Division of Women’s and Perinatal Pathology
§Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Brigham and Women’s Hospital
‡Dana Farber Cancer Institute, Boston MA
†Department of Pathology, Siriraj Hospital, Mahidol University, Bangkok, Thailand
Presented at the 103rd United States and Canadian Academy of Pathology Annual Meeting in San Diego, CA.
C.P.C. and E.E.M. contributed equally.
Conflicts of Interest and Source of Funding: Supported by a grant from the Department of Defense (W81XWH-10-1-0289 to C.P.C.). The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.
Correspondence: Christopher P. Crum, MD, Department of Pathology, Brigham and Women’s Hospital, Boston, MA 02115 (e-mail: [email protected]).
